The regulatory requirements for NMPA registration (National Medical Products Administration) for invasive blood pressure monitoring devices in China encompass several key aspects to ensure safety, efficacy, and quality standards are met. Here are the main regulatory requirements:

Classification

1. Device Classification:
   • Determine the classification of the invasive blood pressure monitoring device according to Chinese regulations (e.g., Class II or III). Classification is based on factors such as intended use, technology, and potential risks.

Quality Management System (QMS)

1. ISO 13485 Certification:
   • Implement and maintain a Quality Management System (QMS) compliant with ISO 13485 or equivalent standards. The QMS should cover design controls, manufacturing processes, risk management, and post-market surveillance.

Technical Documentation

1. Technical File Requirements:
   • Prepare a comprehensive technical file that includes:
     • Device specifications, design drawings, and components.
     • Risk analysis according to ISO 14971.
     • Performance testing and validation data demonstrating device functionality, accuracy, and reliability.
     • Clinical evaluation report (CER) summarizing clinical data supporting device safety and performance.
     • Labeling and Instructions for Use (IFU) in compliance with Chinese regulatory requirements.

Clinical Evaluation

1. Clinical Data:
   • Provide clinical data demonstrating the safety, efficacy, and clinical benefits of the invasive blood pressure monitoring device. This includes data from clinical trials, observational studies, and literature reviews.

Biocompatibility

1. Biocompatibility Testing:
   • Conduct biocompatibility testing according to ISO 10993 standards to demonstrate the device’s biological safety.

Performance Standards

1. Compliance with Standards:
   • Ensure the device complies with relevant Chinese standards (e.g., GB standards) for safety, performance, and efficacy.

Manufacturing Information

1. Manufacturing Details:
   • Provide details of manufacturing processes, facilities, and controls ensuring consistency in device production.

Labeling and Packaging

1. Labeling Requirements:
   • Ensure labeling and packaging comply with Chinese regulations, including instructions for assembly, installation, operation, maintenance, and troubleshooting in both Chinese and English.

Post-Market Surveillance

1. Post-Market Surveillance (PMS):
   • Establish a post-market surveillance system to monitor the device’s performance and report adverse events or product issues to the NMPA as required.

Application and Review Process

1. Application Submission:

   • Submit a complete application for NMPA registration through a qualified local agent or representative.

2. Technical Review:

   • Undergo a technical review by the NMPA to assess compliance with regulatory requirements and standards.

3. Site Inspection (if required):

   • Prepare for and undergo an on-site inspection of manufacturing facilities by the NMPA to ensure compliance with Good Manufacturing Practices (GMP) and quality system requirements.

Renewal and Compliance Maintenance

1. Renewal Application:
   • Renew the registration certificate before its expiration to maintain market authorization in China. This involves demonstrating continued compliance with regulatory requirements.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn